Zyla Life Sciences Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3
Zyla Life Sciences reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 · last filed 2020-03-26
- Zyla Life Sciences fair value, measurement with unobservable inputs reconciliation, recurring basis, asset transfers into level 3 for fiscal 2019 was $0.00.
- Zyla Life Sciences fair value, measurement with unobservable inputs reconciliation, recurring basis, asset transfers into level 3 for fiscal 2018 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-26 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-26 |